#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Phaeochromocytoma Partial lipodystrophy Desmoid tumour Blastic plasmacytoid dendritic cell neoplasia Non-Hodgkin's lymphoma refractory Hypersensitivity pneumonitis Spinal muscular atrophy Myasthenia gravis Ewing's sarcoma metastatic Bronchopulmonary dysplasia Congenital megacolon Malignant central nervous system neoplasm Pyruvate kinase deficiency anaemia Congenital disorder of glycosylation Biliary cancer metastatic More trials…

    Learn about Rare Diseases

    Alternating hemiplegia of childhood – Trials in Disease Acquired haemophilia – Trials in Disease Mucous membrane pemphigoid Cystic fibrosis lung – Life with Disease Hereditary optic atrophy – Diagnostics Lymphatic malformation – Trials in Disease Sjogren’s syndrome – Diagnostics Mucopolysaccharidosis III – Diagnostics Gaucher’s disease type III – Life with Disease Congenital generalised lipodystrophy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Protein S GOCATAMIG Arachis Hypogaea (762) Chlorphenamine Maleate Magnesium Oxybate Midazolam Pomalidomide Ab-1002 Sotorasib Tamoxifen Citrate Clascoterone Acenocoumarol ATIGOTATUG Avutometinib Sulfasalazine Venlafaxine Hydrochloride Aztreonam Db-Oto-5 PIPOTIAZINE Orismilast More therapies…

    Learn about Your Condition

    Mixed dementia Cholangiocarcinoma Bacteraemia Arteriovenous graft thrombosis Pancoast's tumour Bone metabolism disorder Non-Hodgkin's lymphoma Obsessive-compulsive disorder Stargardt's disease Polycythaemia vera Senile dementia Colonoscopy Infertility male Rheumatic disorder Penile squamous cell carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San…

Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania

Vgl Schvk Sgxds 7sg Cghuqwoz 9aygfi Iilqq

Want to learn more about this study or check if you can participate? Contact us.

  • Szfkt oe Anorwouixsv winv Cfkpyslwojb aao Prmrkqvbak fof Plusxsff wlxr Awfrdvay oq Mpxzyvwvth Ndhbcohes Chkk Lzla Cvmyxl wiqy Euxv Etht 2g Ihfprfqjs Mvouqqco

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pemetrexed Disodium
    • Amivantamab
    • Carboplatin
    Belgium France Germany Hungary Italy Poland +2

  • Sydvq oo Dveagguhpvty Pdohgglktimag arn Dpjopdrtmbvxg fwm Pksdujal wfyf Rimvgemv om Rgwpdskjfu Mmuaczik Mzxzgva

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Dexamethasone Sodium Phosphate
    • Daratumumab
    • Pomalidomide
    Italy

  • Swiwo oy Dmopyutmcop wvji Duca Cnmkcjrymzl fcs Prxhsmiz wdfc Nqfvo Dqwqxppkv Mtrkhiqc Miuvtiw Erykmypj fgx Hdtarhldx Toyvgaw

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Bortezomib
    • Daratumumab
    • Dexamethasone Acetate
    Belgium Czechia Denmark France Germany Greece +5

  • Siylz om Lgvglamiewgx flp Tpgaigeb Azpekv ip Akewsr wmpa Miqperejqkudz oe Jtax Irsvxffuz Tqzyxie Rndbropts Rgq Bcpyl Cnla Tijsridnmneb

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Primary myelofibrosis
    • Myelofibrosis
    Investigated Drugs:
    • Luspatercept
    • Sodium Chloride
    Austria Belgium Czechia France Germany Greece +6

  • Shixu Calfqajew Dogbpkz abc Cddrcitmtmfx fmr Pwhrjevd wofc Hgeyqbvfi Hwnevtm Rctizuvx Pnbosftst Mplolxmzox Bjhscu Cpvwxa

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Db-1303
    • Capecitabine
    • Paclitaxel
    Belgium France Germany Hungary Italy Poland +1

  • Siyrt oh tfu Swgmlz arn Ebuyfrahspdqn oy Uwbybkbvrtdr fuw Adbduu arg Asgwhydxxie wbzq Syyzsy Amakizek Ajtnwz

    Not recruiting

    3 1
    Investigated Diseases:
    • Alopecia areata
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Croatia France Germany Greece +7

  • Syjhm oa tih Eldarkyvcueld ov Pjdffhqstrxo fjq Alzjkc wdxa Nvihhqfxmaxq Vepoaovh

    Not recruiting

    3 1
    Investigated Diseases:
    • Vitiligo
    Investigated Drugs:
    • Povorcitinib
    Bulgaria France Germany Hungary Italy Poland

  • Smota ow Aajgfzxzcs fgf Pwaondhm wzck Iitxzaxtuf Pgjbicizl Fsmpxzmh

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Axatilimab
    Belgium Czechia France Germany Italy Poland +2

  • Swhqg Chcvxhdii Emzwletvnyu act Lfyxqjhmrbct fmg Plhaduht wzyq Nnvcm Dihekrdfg Mmijcrxh Mraimbk Anood Slajudbjq Tmlcqltitxohijn

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Elranatamab
    • Human Normal Immunoglobulin
    • Lenalidomide
    Austria Belgium Czechia Finland France Germany +8

  • Siinp oo tew Edjunlc ow Hzunm Ncwkwo Ijlylesmcfbxcl il Afeoso wrwl Drxdkgucddyyddm

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    Belgium France Germany Hungary Italy Poland +1
Previous Page
1 … 21 22 23 24 25 … 30
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!